Position in ILMN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$419,178
+$122,122 QoQ
Shares Held
2,384
-1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#596
of 936 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Linden Thomas Advisory Services, LLC holds $20,745,859 across 10 Diagnostics & Research names. ILMN ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
13,803 | $6,920,272 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
7,872 | $4,144,135 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
2,271 | $2,901,225 | |
| 4 | DGX |
Quest Diagnostics Inc
|
12,539 | $2,657,641 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
3,766 | $1,994,435 | |
| 6 | RVTY |
Revvity, Inc.
|
7,837 | $871,944 | |
| 7 | ILMN |
Illumina, Inc.
This page
|
2,384 | $419,178 | |
| 8 | DHR |
Danaher Corp /De/
|
1,767 | $336,578 |
All Filings in ILMN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $419,178 | 2,384 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $297,056 | 2,410 | Shares | Sole | 2026-04-10 | |
| 2024-03-31 | $1,198,666 | 8,729 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,286,856 | 9,242 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,246,090 | 9,077 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $767,396 | 4,093 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $922,758 | 3,968 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $717,607 | 3,549 | Shares | Sole | 2023-02-17 | |
| No filing history on record for this holder in this stock. | ||||||